Biomaterials Science · 2018 · 58 citations · 35 references
PharmacyMicrobiologyPharmaceuticsDrug DeliveryNanomaterialsNanoparticle Drug DeliveryAntibiotic ResistanceInorganic NanoparticlesMultidrug ResistanceNanomaterials For Drug DeliveryNanomedicinePh-responsive Drug DeliveryAntimicrobial NanomaterialsAntimicrobial NanomedicineBacterial Multidrug ResistanceDrug Delivery NanocarriersMesoporous Silica NanomaterialsMesoporous Silica NanoparticlesMultifunctional NanoparticlesPh-responsive Nanocarriers
Efflux pump system-mediated bacterial multidrug resistance is one of the main causes of antibiotic failure. Therefore, it is necessary to develop a novel nanocarrier that could effectively inhibit drug-resistant bacteria by increasing the intake and retention time of antibiotics. Herein, we constructed a pH-responsive nanocarrier (MSN@FA@CaP@FA) with double folic acid (FA) and calcium phosphate (CaP) covered on the surface of mesoporous silica (MSN) by electrostatic attraction and biomineralization, respectively. Afterward, loading the nanocomposites with ampicillin (Amp) effectively increased the uptake and reduced the efflux effect in Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) by the specific targeting of FA. Moreover, Amp-MSN@FA@CaP@FA could specifically transport Amp to the bacterial infection site. Similarly, antibacterial experiments revealed that the Amp-MSN@FA@CaP@FA could significantly enhance the activity of Amp for inhibiting drug-resistant bacteria, without producing drug resistance. Additionally, the Amp-MSN@FA@CaP@FA could reduce the content of protein and inhibit the protein activity in drug-resistant bacteria, so that it destroyed the bacterial membrane and led to the bacteria death. In vivo antibacterial experiments showed that the Amp-MSN@FA@CaP@FA could effectively reduce the mortality of drug-resistant E. coli infection and promote wound healing of drug-resistant S. aureus infection. In summary, Amp-MSN@FA@CaP@FA has a potential for application in sustained-release nanostructures and to inhibit drug-resistant bacteria.
35
Predictive compound accumulation rules yield a broad-spectrum antibiotic
Michelle F. Richter, Bryon Drown, Andrew P. Riley et al. · Nature · 2017 · 886 citations
Near‐Infrared Light‐Triggered, Targeted Drug Delivery to Cancer Cells by Aptamer Gated Nanovehicles
Xinjian Yang, Xia Liu, Zhen Liu et al. · Advanced Materials · 2012 · 418 citations
Pharmacy, Oncology, Pharmaceutics +17
Tunable Redox-Responsive Hybrid Nanogated Ensembles
Rui Liu, Xiang Zhao, Tao Wu et al. · Journal of the American Chemical Society · 2008 · 389 citations